Floatz logo

CBL-0137 FREE BASE

Metastatic Malignant Neoplasm in the Central Nervous System

Children's Oncology GroupSmall moleculePhase 1/2Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Metastatic Malignant Neoplasm in the Central Nervous System cohort.

Asset / SponsorPhaseRating
Brigatinib
Sameek Roychowdhury
Phase 2CCC
wsd0922-fu
Mayo Clinic
Phase 1CC
Dabrafenib
Mayo Clinic
Phase 1CC
E-6201
Mayo Clinic
Phase 1D

Same molecule, other indications

CBL-0137 FREE BASE is also rated in:

diffuse intrinsic pontine gliomaDormant
CC
Indicative ·
44 / 100
View asset →
diffuse midline glioma, H3 K27-alteredDormant
CC
Indicative ·
44 / 100
View asset →
lymphomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →